Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double …
BACKGROUND: Individual response to oral antiplatelet therapy is subject to variability, and
bedside monitoring offers the opportunity of individualizing therapy for stent implantation …
bedside monitoring offers the opportunity of individualizing therapy for stent implantation …
Impact of aspirin and clopidogrel hyporesponsiveness in patients treated with drug-eluting stents: 2-year results of a prospective, multicenter registry study
TD Stuckey, AJ Kirtane, BR Brodie… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists
DJ Angiolillo, S Suryadevara… - Catheterization and …, 2009 - Wiley Online Library
Antiplatelet therapy is the cornerstone of treatment for patients with acute coronary
syndrome and is also of particular importance in those who undergo percutaneous coronary …
syndrome and is also of particular importance in those who undergo percutaneous coronary …
[HTML][HTML] Bedside monitoring to adjust antiplatelet therapy for coronary stenting
Background Patients' responses to oral antiplatelet therapy are subject to variation. Bedside
monitoring offers the opportunity to improve outcomes after coronary stenting by …
monitoring offers the opportunity to improve outcomes after coronary stenting by …
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: a landmark analysis of the ARCTIC study
G Montalescot, G Range, J Silvain, JL Bonnet… - Circulation, 2014 - Am Heart Assoc
Background—Individualizing antiplatelet therapy after platelet function testing did not
improve outcome after coronary stenting in the Assessment by a Double Randomization of a …
improve outcome after coronary stenting in the Assessment by a Double Randomization of a …
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the …
BACKGROUND: The inhibitory response to clopidogrel varies widely among individuals.
Data suggest that patients with high residual platelet reactivity despite clopidogrel therapy …
Data suggest that patients with high residual platelet reactivity despite clopidogrel therapy …
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
MJ Price, S Endemann, RR Gollapudi… - European heart …, 2008 - academic.oup.com
Aims The aim of this study was to determine whether platelet reactivity on clopidogrel
therapy, as measured by a point-of-care platelet function assay, is associated with …
therapy, as measured by a point-of-care platelet function assay, is associated with …
Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation
TG Nührenberg, C Stratz, S Leggewie… - Thrombosis and …, 2015 - thieme-connect.com
Given conflicting data on temporal variability in pharmacodynamic platelet responses to
clopidogrel, we investigated platelet reactivity on clopidogrel and aspirin for up to six months …
clopidogrel, we investigated platelet reactivity on clopidogrel and aspirin for up to six months …
[HTML][HTML] Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis …
AR Hobson, G Petley, G Morton, KD Dawkins… - Thrombosis …, 2008 - Springer
Background To test the hypothesis that point-of-care assays of platelet reactivity would
demonstrate reduced response to antiplatelet therapy in patients who experienced Drug …
demonstrate reduced response to antiplatelet therapy in patients who experienced Drug …
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint …
Background Elderly patients are at high risk of ischaemic and bleeding events. Platelet
function monitoring offers the possibility to individualise antiplatelet therapy to improve the …
function monitoring offers the possibility to individualise antiplatelet therapy to improve the …